We are live on ! Find out more
VIVS

VivoSim Labs

29 hedge funds and large institutions have $1.24M invested in VivoSim Labs in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% less ownership

Funds ownership: 1.35%1.32% (-0.03%)

12% less funds holding

Funds holding: 3329 (-4)

30% less capital invested

Capital invested by funds: $1.77M → $1.24M (-$531K)

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
29
Holders Change
-4
Holders Change %
-12.12%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
10
Closed
6
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change
-$5K

VIVS Hedge Fund Activity: Q3 2024 in Review

29 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2024, worth a combined $1.24M — down 30% from $1.77M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VIVS and 2 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.

The largest buyer was Armistice Capital, adding an estimated $168K. The largest seller was Citadel Advisors, cutting an estimated $44.6K.

  • 29 institutional investors held VivoSim Labs (VIVS) as of Q3 2024, down from 33 in Q2 2024.
  • Funds reported $1.24M of VivoSim Labs stock for Q3 2024, down 30% quarter-over-quarter.
  • 2 funds opened new VivoSim Labs positions in Q3 2024 and 6 closed out, a net change of -4 holders.
  • The largest VivoSim Labs buyer in Q3 2024 was Armistice Capital, an estimated $168K added.
  • The largest VivoSim Labs seller in Q3 2024 was Citadel Advisors, an estimated $44.6K sold.

Based on aggregated 13F filings for Q3 2024.